Signals 03: January 2026

From China to France to your Hospital and Living Room

Welcome back to Signals, a members-only newsletter analyzing key commercial developments across the neurotech industry each month.

January is always a busy stretch with JPM, CES, NANS, and Davos. This edition covers seven of the top deals from last month:

• BrainCo’s fundraise and China’s growing neurotech industry

• Neurolief’s PMA for at-home depression treatment

• Precision’s partnership with Medtronic creates a commercial foothold

• Naox’s FDA approval for in-ear EEG

• Omniscient’s CPT codes & Funding momentum

• Surf Therapeutics’ EFS for inflammatory disease

• Spiros’ $67m Series A for novel asthma neuromod

As always there were other interesting stories that we didn’t get to in this edition. Your feedback and suggestions are always welcome. Let’s dive in.